IPO - Gain Therapeutics, Inc.

Form Type: 8-K

Filing Date: 2025-07-17

Corporate Action: Ipo

Type: New

Accession Number: 000110465925068530

Filing Summary: On July 16, 2025, Gain Therapeutics, Inc. entered into an underwriting agreement with Newbridge Securities Corporation for the public offering of 4,501,640 shares of common stock and warrants to purchase an additional 2,250,820 shares, projected to raise approximately $7.0 million. The public offering price was set at $3.11 for two shares and one warrant, translating to $1.55 per share and $0.01 per warrant. Warrants have an exercise price of $1.65 and are exercisable for five years. The net proceeds anticipated are about $6.3 million after expenses. The closing of the Offering is targeted for July 17, 2025, contingent upon meeting customary conditions. The company has also set restrictions on stock issuances for 90 days following the agreement's date. The document includes references to relevant exhibits such as the Underwriting Agreement and opinions regarding the securities involved.